John A. Lewicki, EVP & Chief Scientific Officer at OncoMed Pharmaceuticals Inc (OMED), sold 17,000 shares at $24.92 ($426K) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($426k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.92 | 8,500 | $212K | 49.7% |
| 2 | $25.22 | 8,500 | $214K | 50.3% |
| Total | $25.07 avg | 17,000 | $426K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |